Michael W Fried1, Julie M Crawford1, Andrea R Mospan1, Stephanie E Watkins1, Breda Munoz1, Richard C Zink1, Sherry Elliott2, Kyle Burleson1, Charles Landis3, K Rajender Reddy4, Robert S Brown5. 1. TARGET PharmaSolutions Inc., Durham, North Carolina, USA. 2. Elliott Health Information Pros Inc., Cary, North Carolina, USA. 3. Liver Care and Transplantation Services at University of Washington Medical Center, Seattle, Washington, USA. 4. Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 5. Department of Medicine, Division of Gastroenterology and Hepatology, Weill Cornell Medicine Center for Liver Disease, New York, New York, USA.
Abstract
BACKGROUND: As coronavirus disease 2019 (COVID-19) disseminates throughout the United States, a better understanding of the patient characteristics associated with hospitalization, morbidity, and mortality in diverse geographic regions is essential. METHODS: Hospital chargemaster data on adult patients with COVID-19 admitted to 245 hospitals across 38 states between 15 February and 20 April 2020 were assessed. The clinical course from admission, through hospitalization, and to discharge or death was analyzed. RESULTS: A total of 11 721 patients were included (majority were >60 years of age [59.9%] and male [53.4%]). Comorbidities included hypertension (46.7%), diabetes (27.8%), cardiovascular disease (18.6%), obesity (16.1%), and chronic kidney disease (12.2%). Mechanical ventilation was required by 1967 patients (16.8%). Mortality among hospitalized patients was 21.4% and increased to 70.5% among those on mechanical ventilation. Male sex, older age, obesity, geographic region, and the presence of chronic kidney disease or a preexisting cardiovascular disease were associated with increased odds of mechanical ventilation. All aforementioned risk factors, with the exception of obesity, were associated with increased odds of death (all P values < .001). Many patients received investigational medications for treatment of COVID-19, including 48 patients on remdesivir and 4232 on hydroxychloroquine. CONCLUSIONS: This large observational cohort describes the clinical course and identifies factors associated with the outcomes of hospitalized patients with COVID-19 across the United States. These data can inform strategies to prioritize prevention and treatment for this disease.
BACKGROUND: As coronavirus disease 2019 (COVID-19) disseminates throughout the United States, a better understanding of the patient characteristics associated with hospitalization, morbidity, and mortality in diverse geographic regions is essential. METHODS: Hospital chargemaster data on adult patients with COVID-19 admitted to 245 hospitals across 38 states between 15 February and 20 April 2020 were assessed. The clinical course from admission, through hospitalization, and to discharge or death was analyzed. RESULTS: A total of 11 721 patients were included (majority were >60 years of age [59.9%] and male [53.4%]). Comorbidities included hypertension (46.7%), diabetes (27.8%), cardiovascular disease (18.6%), obesity (16.1%), and chronic kidney disease (12.2%). Mechanical ventilation was required by 1967 patients (16.8%). Mortality among hospitalized patients was 21.4% and increased to 70.5% among those on mechanical ventilation. Male sex, older age, obesity, geographic region, and the presence of chronic kidney disease or a preexisting cardiovascular disease were associated with increased odds of mechanical ventilation. All aforementioned risk factors, with the exception of obesity, were associated with increased odds of death (all P values < .001). Many patients received investigational medications for treatment of COVID-19, including 48 patients on remdesivir and 4232 on hydroxychloroquine. CONCLUSIONS: This large observational cohort describes the clinical course and identifies factors associated with the outcomes of hospitalized patients with COVID-19 across the United States. These data can inform strategies to prioritize prevention and treatment for this disease.
Authors: Stéphane M Meystre; Paul M Heider; Youngjun Kim; Matthew Davis; Jihad Obeid; James Madory; Alexander V Alekseyenko Journal: J Am Med Inform Assoc Date: 2021-12-28 Impact factor: 7.942
Authors: Miguel Ángel Palacios-Pedrero; Albert D M E Osterhaus; Tanja Becker; Husni Elbahesh; Guus F Rimmelzwaan; Giulietta Saletti Journal: Front Immunol Date: 2021-05-12 Impact factor: 7.561
Authors: Juan Pablo Domecq; Amos Lal; Christopher R Sheldrick; Vishakha K Kumar; Karen Boman; Scott Bolesta; Vikas Bansal; Michael O Harhay; Michael A Garcia; Margit Kaufman; Valerie Danesh; Sreekanth Cheruku; Valerie M Banner-Goodspeed; Harry L Anderson; Patrick S Milligan; Joshua L Denson; Catherine A St Hill; Kenneth W Dodd; Greg S Martin; Ognjen Gajic; Allan J Walkey; Rahul Kashyap Journal: Crit Care Med Date: 2021-03-01 Impact factor: 9.296
Authors: Benjamin P Wankum; Riley E Reynolds; Andrea R McCain; Nathaniel T Zollinger; Keely L Buesing; Russel D Sindelar; Frank M Freihaut; Tariku Fekadu; Benjamin S Terry Journal: J Anesth Date: 2021-06-01 Impact factor: 2.078
Authors: Austin J Parish; Jason R West; Nicholas D Caputo; Trevor M Janus; Denley Yuan; John Zhang; Daniel J Singer Journal: Crit Care Explor Date: 2021-06-15